Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and mannitol for prevention of postoperative SIRS after PCNL
IRCT20190624043991N32Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone and Bronchitol in nephrolithiasis (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: C-reactive protein, erythrocyte sedimentation rate and 1 more. Started Jan 2026; status: completed.
02
Drugs
dexamethasoneBronchitol
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20190624043991N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N32.